Cargando…

EPS4.4 Correlation between long-term changes in LCI, FEV(1) and CFCT score in children with cystic fibrosis

Detalles Bibliográficos
Autores principales:	Vermeulen, F., Boon, M., Proesmans, M., De Boeck, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. Published by Elsevier B.V. 2017
Materias:	E-Poster Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130030/ http://dx.doi.org/10.1016/S1569-1993(17)30305-3

Ejemplares similares

ePS4.08 COVID-19 vaccine uptake in adult people with cystic fibrosis
por: Mir, M.H., et al.
Publicado: (2022)

ePS4.03 Outcomes of COVID-19 in patients with cystic fibrosis in Wales, UK
por: Lau, D., et al.
Publicado: (2022)

ePS4.09 COVID-19 vaccination in households of paediatric cystic fibrosis patients - experience of The Cystic Fibrosis Centre in Zagreb, Croatia
por: Bambir, I., et al.
Publicado: (2022)

ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC)
por: Lucca, F., et al.
Publicado: (2022)

ePS4.04 Evaluation of burden of the COVID-19 pandemic among the cystic fibrosis community in Brno, Czech Republic
por: Mala, M., et al.
Publicado: (2022)

ePS4.05 Evolving cystic fibrosis care during COVID-19: a single-centre experience
por: Spoletini, G., et al.
Publicado: (2022)

EPS1.07 Impact of COVID-19 on cystic fibrosis physiotherapy outpatient clinics
por: Scott, E., et al.
Publicado: (2021)

ePS1.05 Impact of COVID-19 on mental health among people with cystic fibrosis
por: Chrysochoou, E.-A., et al.
Publicado: (2022)

EPS1.04 Audit of virtual exercise class during COVID-19 in children with cystic fibrosis
por: Johnstone, Z., et al.
Publicado: (2021)

ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Alicandro, G., et al.
Publicado: (2022)

ePS4.01 The impact of the SARS-CoV-2 pandemic on people with cystic fibrosis (CF) in Ireland: did individuals maintain their key health outcomes?
por: Rees, H., et al.
Publicado: (2022)

EPS2.04 The role of Flash Glucose Monitoring System at annual review during the COVID-19 restrictions, within Cystic Fibrosis Diabetes Service at Blackpool Adult Cystic Fibrosis Centre, UK
por: Connolly, A., et al.
Publicado: (2021)

ePS1.04 Sleep disturbances in children with cystic fibrosis at the beginning and in the first year of the COVID-19 pandemic
por: Eyuboglu, T. Sismanlar, et al.
Publicado: (2022)

EPS1.05 Evaluating impacts of the change from clinic to home spirometry on clinicians and adults with cystic fibrosis
por: Daniels, T., et al.
Publicado: (2021)

EPS1.01 Physiotherapy practice of French cystic fibrosis children changed during lockdown due to COVID-19 pandemic
por: Mittaine, M., et al.
Publicado: (2021)

EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK
por: Brown, C., et al.
Publicado: (2021)

EPS2.07 How did the COVID-19 lockdown influence the nutritional status and body composition of cystic fibrosis patients in Poland?
por: Mielus, M., et al.
Publicado: (2021)

ePS1.06 Evolution of psychological distress during progression of the COVID-19 pandemic in adults with cystic fibrosis
por: Cresta, F., et al.
Publicado: (2022)

ePS4.10 Evaluation of possible adverse events in relationship to the SARS-CoV-2 vaccination in cystic fibrosis patients with or without lung transplantation: a retrospective single-centre case series
por: Gautschi, F., et al.
Publicado: (2022)

EPS1.06 A retrospective audit of home-based spirometry quality in a large UK adult cystic fibrosis centre
por: Waller, I., et al.
Publicado: (2021)

ePS1.02 Long-term psychological impact of COVID-19 on adult patients with cystic fibrosis, including transplanted patients
por: Havermans, T., et al.
Publicado: (2022)

ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity
por: Lausen, M., et al.
Publicado: (2022)

EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis
por: Hatziagorou, E., et al.
Publicado: (2021)

ePS1.07 Parental experiences of face-to-face versus virtual cystic fibrosis clinics during the COVID-19 pandemic: questionnaire study
por: Lock, K., et al.
Publicado: (2022)

ePS5.02 Effect of omalizumab on glucocorticoid use and lung function in the treatment of allergic bronchopulmonary aspergillosis in people with cystic fibrosis: a systematic review and meta-analysis
por: Elborn, J.S., et al.
Publicado: (2022)

Use of Nebulized Amphotericin B in the Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
por: Proesmans, M., et al.
Publicado: (2010)

ePS1.03 The impact of the COVID-19 lockdown and introduction of precision medication Symkevi and Orkambi on cystic fibrosis patients at Sheffield Children’s NHS Foundation Trust, UK (SCFT)
por: Braisdell, K., et al.
Publicado: (2022)

Computed cardiopulmonography and the idealized lung clearance index, iLCI(2.5), in early-stage cystic fibrosis
por: Sandhu, Dominic, et al.
Publicado: (2023)

How Does the Corrected Exhalyzer Software Change the Predictive Value of LCI in Pulmonary Exacerbations in Children with Cystic Fibrosis?
por: Wojsyk-Banaszak, Irena, et al.
Publicado: (2023)

Is LCI the best for virtual chromoendoscopy?
por: Arantes, Vitor, et al.
Publicado: (2019)

The Cone Flare Crush Modified-T (CFCT) stenting technique for coronary artery bifurcation lesions
por: Peverill, William T., et al.
Publicado: (2020)

EPS4.6 Inherent differences in multiple breath washout (MBW) using N(2) and SF(6) demonstrated by simultaneous analysis with respiratory mass spectrometry (RMS)
por: Bayfield, K.J., et al.
Publicado: (2017)

Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis
por: Boëlle, Pierre-Yves, et al.
Publicado: (2012)

O.4.4-10 Policy and environmental correlates of physical activity in Croatia
por: Jukić, Anja Maria, et al.
Publicado: (2023)

Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis
por: Bouzek, Drake C., et al.
Publicado: (2022)

EPS3.05 N-chlorotaurine is a very promising antiseptic treatment option for multiresistant bacteria, fungi and for viruses including SARS-CoV-2
por: Schwarz, C., et al.
Publicado: (2021)

O.4.4-1 Moving messages: development of the physical activity messaging framework and checklist
por: Williamson, Chloë, et al.
Publicado: (2023)

Understanding the natural progression in %FEV(1) decline in patients with cystic fibrosis: a longitudinal study
por: Taylor-Robinson, David, et al.
Publicado: (2012)

Routine spirometry in cystic fibrosis patients: impact on pulmonary exacerbation diagnosis and FEV(1) decline
por: de Aquino, Carolina Silva Barboza, et al.
Publicado: (2022)

Best practices in the treatment of early cystic fibrosis lung disease
por: Proesmans, Marijke
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6u8tc5v7e5rtp0mvf356vo3gsc